The HLM score was constructed based on six genes, AGXT, TRIB2, ELFN2, PCDHB10, CALCA, and CD79A, which have been previously reported to be associated with the tumorigenesis and progression of various cancer types, including CRC, as well as chemotherapy resistance [65–69]. The gene discussed is ELFN2; the disease is colorectal carcinoma.